Harvard X logo

FDA and Prescription Drugs: A Free, Online Course from HarvardX

Available March 26, 2019, a new course “FDA and Prescription Drugs: Current Controversies in Context” will be offered at no cost via the HarvardX online platform (part of the non-profit EdX consortium).  It is designed around a 6-week, self-paced schedule, and features expert guest speakers including former FDA commissioner Margaret Hamburg.

Video lectures, delivered by Harvard faculty from the Program on Regulation, Therapeutics, and Law (PORTAL), cover FDA history, expedited drug development, Right-to-Try, industry user fees, cancer treatments, Orphan drugs, dietary supplements, high prices, post-market surveillance, advertising, and much more. Starts March 26. Any interested person can preview the course trailer and enroll here (open to everyone).  #HarvardXFDA

Jonathan Darrow

Jonathan Darrow

Jonathan J. Darrow was a Student Fellow during the 2012-2013 academic year. Currently, he is a faculty member at Harvard Medical School and is a member of the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham & Women's Hospital. He holds degrees in biological sciences / genetics, law, and business from Cornell, Duke, and Boston College, respectively, as well as a research doctorate in pharmaceutical policy and intellectual property theory from Harvard Law School, where he also completed the LL.M. program. He has been qualified as a patent attorney since 2002. After admission to the California bar in 2001, Dr. Darrow worked on pharmaceutical litigation matters at Wiley Rein & Fielding in Washington, DC, taught on the business law faculties of three universities (2004-2014), served as a senior law clerk for a federal appellate judge, and explored the relationship between innovation policy and global health in service to the World Trade Organization, the World Health Organization, and the World Intellectual Property Organization. He is a co-author of three textbooks, including Cyberlaw: Management & Entrepreneurship (2015) and The Legal and Ethical Environment of Business (forthcoming 2018). His scholarship on health policy and intellectual property has appeared in the British Medical Journal, the New England Journal of Medicine; the Journal of Law, Medicine & Ethics; the Stanford Technology Law Review; the Yale Journal of Health Policy Law & Ethics; and Health Affairs, among many others, and he has testified before a committee of the Massachusetts legislature on an emerging issue of law and technology. He authored Crowdsourcing Clinical Trials (Minnesota L Rev 2014) as part of his Student Fellowship.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.